Item 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

Recursion Pharmaceuticals, Inc. (the "Company") held its 2022 annual meeting of stockholders ("Annual Meeting") on June 14, 2022. At the Annual Meeting, the holders of 118,818,276 shares of the Company's Class A common stock ("Class A Common Stock") and 8,269,209 shares of the Company's Class B common stock ("Class B Common Stock") were present virtually or by proxy, representing an aggregate of approximately 81.88% of the combined voting power of all issued and outstanding shares of Class A Common Stock and Class B Common Stock entitled to vote at the Annual Meeting, which constituted a quorum for the transaction of business. In deciding on the proposals at the Annual Meeting, the holders of the Class A Common Stock were entitled to one vote for each share held as of the close of business on April 18, 2022 (the "Record Date") and the holders of the Class B Common Stock were entitled to 10 votes for each share held as of the close of business on the Record Date. The Class A Common Stock and Class B Common Stock voted as a single class on all matters.

At the Annual Meeting, the Company's stockholders voted on the following two proposals, each of which is described in more detail in the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 28, 2022:



    1.   The stockholders elected as Class I directors the three individuals
         listed below to serve until the Company's 2025 annual meeting of
         stockholders, or until their respective successors are duly elected and
         qualified. The voting results were as follows:



            Name                 Votes For     Withheld    Broker Non-Votes
Zachary Bogue, J.D.             155,532,902   9,276,806       36,700,658
Zavain Dar                      149,499,724   15,309,984      36,700,658

Robert Hershberg, M.D., Ph.D. 145,878,263 18,931,445 36,700,658





    2.   The stockholders ratified the appointment of Ernst & Young LLP as the
         Company's independent registered public accounting firm for the fiscal
         year ending December 31, 2022. The voting results were as follows:



 Votes For    Votes Against   Abstentions   Broker Non-Votes
201,362,410      112,434        35,522             -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses